The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Mitigating Risks of Compounded Drugs Through Surveillance FDA Risk Control Safety Assessment ELSIE Consortium BPC157, TB500, GHK Cu FDA FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC